Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun;54(6):2712-5.
doi: 10.1128/AAC.01736-09. Epub 2010 Mar 29.

Activity of drug combinations against dormant Mycobacterium tuberculosis

Affiliations

Activity of drug combinations against dormant Mycobacterium tuberculosis

Perla Filippini et al. Antimicrob Agents Chemother. 2010 Jun.

Abstract

Aerobic (5-day-old cultures) and nonreplicating (dormant) Mycobacterium tuberculosis (5-, 12-, and 19-day-old cultures) bacteria were treated with rifampin (R), moxifloxacin (MX), metronidazole (MZ), amikacin (AK), or capreomycin (CP) for 7, 14, and 21 days. R-MX-MZ-AK and R-MX-MZ-CP killed both aerobic and dormant bacilli in 21 days, as shown by lack of regrowth in solid and liquid media. R-MX-MZ-AK and R-MX-MZ-CP also caused a strong decrease of nonreplicating bacilli in 7 days in a cell-based dormancy model.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Survival of M. tuberculosis in the Wayne dormancy culture model after 7, 14, and 21 days of exposure to drugs, as estimated by CFU counts. Five-day-old aerobic (A5), replicating cultures were incubated with drugs. Five-, 12-, and 19-day-old hypoxic (H5, H12, and H19, respectively), nonreplicating cultures were incubated with drugs. Dashed lines indicated the limits of log10 CFU per milliliter detected on Middlebrook 7H10 plates (5 CFU/ml). R, rifampin; MX, moxifloxacin; MZ, metronidazole; AK, amikacin; CP, capreomycin. Error bars, standard deviations.
FIG. 2.
FIG. 2.
Survival of M. tuberculosis in the Wayne dormancy culture model after 7, 14, and 21 days of exposure to drugs, as estimated by regrowth in liquid medium (day to positivity [DTP]) by using the BACTEC MGIT 960 system. Five-day-old aerobic (A5), replicating cultures were incubated aerobically with drugs. Five-, 12-, and 19-day-old hypoxic (H5, H12, and H19, respectively), nonreplicating cultures were incubated anaerobically with drugs. R, rifampin; MX, moxifloxacin; MZ, metronidazole; AK, amikacin; CP, capreomycin. In panels G to L, DTP of R-MX and R-MX-MZ are shown (dashed lines) for a better comparison of overall results. Means and standard deviations from three experiments are shown.
FIG. 3.
FIG. 3.
Survival of nonreplicating M. tuberculosis bacilli inside adipocytes after 7 days of exposure to drugs, as estimated by CFU counts. R, rifampin; MX, moxifloxacin; MZ, metronidazole; AK, amikacin; CP, capreomycin. Means and standard deviations from triplicate plates of one representative experiment out of two are shown.

References

    1. Barry, C. E., III, H. I. Boshoff, and C. S. Dowd. 2004. Prospects for clinical introduction of nitroimidazole antibiotics for the treatment of tuberculosis. Curr. Pharm. Des. 10:3239-3262. - PubMed
    1. Barry, C. E., III, H. I. Boshoff, V. Dartois, T. Dick, S. Ehrt, J. Flynn, D. Schnappinger, R. J. Wilkinson, and D. Young. 2009. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 7:845-855. - PMC - PubMed
    1. Cho, S. H., S. Warit, B. Wan, C. H. Hwang, G. F. Pauli, and S. G. Franzblau. 2007. Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 51:1380-1385. - PMC - PubMed
    1. Edwards, D. I. 1993. Nitroimidazole drugs—action and resistance mechanisms. I. Mechanisms of action. J. Antimicrob. Chemother. 31:9-20. - PubMed
    1. Heifets, L., J. Simon, and V. Pham. 2005. Capreomycin is active against non-replicating M. tuberculosis. Ann. Clin. Microbiol. Antimicrob. 4:6. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources